Regarding the model that increased Rap1B geranylgeranylation and thereby increased cell adhesion decreases metastasis, A2AAR and A2BAR antagonists are promising candidates for therapeutic intervention in different types of cancer that overexpress Rap1B. Here, RAP1B is linked to cancer.